BioCentury
ARTICLE | Politics & Policy

EMA updates conflict-of-interest policy

November 21, 2014 2:56 AM UTC

EMA published its revised conflict-of-interest policy, clarifying which levels of conflict are tied to certain restrictions upon who can serve as experts or scientific committee members.

The new policy precludes in perpetuity former pharma executives from serving in agency activities for any medical product for which the company holds marketing authorization. The "lifetime non-involvement" stipulation also prevents employees who had a "lead role" in the development of a product from participating in agency activities related to that product. ...